ALPS Medical Breakthroughs ETF
SBIO
2 hedge funds and large institutions have $1.41M invested in ALPS Medical Breakthroughs ETF in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$1.4M |
| 2 |
Creative Planning
Overland Park,
Kansas
|
+$9.94K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VKH
1
Virtu KCG Holdings
New York
| $1.4M | +$1.4M | +56,393 | New |
|
|
2
Creative Planning
Overland Park,
Kansas
| $10K | +$9.94K | +400 | New |
|
SBIO Hedge Fund Activity: Q4 2014 in Review
2 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q4 2014, worth a combined $1.41M.
Buyers outnumbered sellers: 2 funds opened new SBIO positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $1.4M.
- 2 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q4 2014, up from 0 in Q3 2014.
- Funds reported $1.41M of ALPS Medical Breakthroughs ETF stock for Q4 2014.
- 2 funds opened new ALPS Medical Breakthroughs ETF positions in Q4 2014 and 0 closed out, a net change of +2 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q4 2014 was Virtu KCG Holdings, an estimated $1.4M added.
Based on aggregated 13F filings for Q4 2014.